Michael Theisen

Michael Theisen

Professor

Member of:

  • GLURP team


  1. 2024
  2. Published

    A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults

    Tiono, A. B., Plieskatt, J. L., Ouedraogo, A., Soulama, B. I., Miura, K., Bougouma, E. C., Naghizadeh, M., Barry, A., Yaro, J. B. B., Ezinmegnon, S., Henry, N., Ofori, E. A., Adu, B., Singh, S. K., Konkobo, A., Lövgren Bengtsson, K., Diarra, A., Carnrot, C., Reimer, J. M., Ouedraogo, A. & 6 others, Tienta, M., Long, C. A., Ouedraogo, I. N., Sagara, I., Sirima, S. B. & Theisen, Michael, 1 Apr 2024, In: The Journal of Clinical Investigation. 134, 7, p. e175707 e175707.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Clinical formulation development of Plasmodium falciparum malaria vaccine candidates based on Pfs48/45, Pfs230, and PfCSP

    Plieskatt, J., Bang, P., Wood, G. K., Naghizadeh, Mohammad, Singh, S. K., Jore, M. M. & Theisen, Michael, 16 Mar 2024, In: Vaccine. p. 1980-1992

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Production and purification of Plasmodium circumsporozoite protein in Lactococcus lactis

    Naghizadeh, Mohammad, Singh, S. K., Plieskatt, J., Ofori, Ebenezer Addo & Theisen, Michael, 2024, Recombinant Glycoproteins: Methods and Protocols. Bradfute, S. B. (ed.). Humana Press, p. 109-121 13 p. (Methods in molecular biology (Clifton, N.J.), Vol. 27521).

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

ID: 10528769